Addressing Anxiety and Stress for Healthier Eating in Teens
Launched by THE METIS FOUNDATION · Aug 31, 2021
Trial Information
Current as of May 23, 2025
Unknown status
Keywords
ClinConnect Summary
This study is a randomized controlled trial in which 40 adolescent girls aged 12-17 years-old with weight in the 75th percentile or higher for their age and sex, and elevated anxiety symptoms, will be randomly assigned to an IPT or CBT 12-week group intervention. Approximately 20 adolescent girls will be enrolled at each of two sites: Uniformed Services University (USU) and Colorado State University (CSU). After a screening and baseline assessment, participants will attend an individual meeting with the leaders of their assigned group to learn more about the group process and establish goal...
Gender
FEMALE
Eligibility criteria
- Participant Inclusion Criteria:
- • 12-17-year-old adolescent girls
- • BMI ≥ 75th percentile
- • Anxiety symptoms: 32 or higher on State Trait Anxiety Inventory for Children-Trait Scale
- Participant Exclusion Criteria:
- • Any medical condition (as well as pregnancy or breastfeeding)
- • Individuals who have any DSM psychiatric disorder that, in the opinion of the investigators, would impede competence or compliance or possibly hinder completion of the study
- • Medication impacting mood or weight
- • Psychotherapy
About The Metis Foundation
The Metis Foundation is a dedicated clinical trial sponsor focused on advancing medical research and innovation to improve patient outcomes. With a commitment to ethical practices and scientific rigor, the Foundation collaborates with healthcare professionals, academic institutions, and industry partners to facilitate the development of novel therapies and interventions. By prioritizing patient safety and data integrity, the Metis Foundation aims to contribute to the growing body of knowledge in various medical fields and support the translation of research findings into effective clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Fort Collins, Colorado, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials